C4 Therapeutics Lands $73,000,000 Series A Round

  • Feed Type
  • Date
  • Company Name
    C4 Therapeutics
  • Mailing Address
    Undisclosed Cambridge, MA 10018 USA
  • Company Description
    C4 Therapeutics is developing a new class of targeted protein degradation (TPD) therapeutics for the treatment of a broad range of diseases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The Company is developing novel treatments in the field of targeted protein degradation using proprietary Degronimid technology.
  • M&A Terms
  • Venture Investor
    Cobro Ventures
  • Venture Investor
    Cormorant Asset Management
  • Venture Investor
    The Kraft Group

Trending on Xconomy